Ventricular septal defect
DJ Penny, GW Vick - The Lancet, 2011 - thelancet.com
Ventricular septal defects account for up to 40% of all congenital cardiac malformations. The
diagnosis encompasses a broad range of anomalies, including isolated defects and those …
diagnosis encompasses a broad range of anomalies, including isolated defects and those …
Pulmonary arterial hypertension associated with congenital heart disease
M D'Alto, VS Mahadevan - European Respiratory Review, 2012 - Eur Respiratory Soc
Pulmonary arterial hypertension (PAH) is a common complication of congenital heart
disease (CHD), with most cases occurring in patients with congenital cardiac shunts. In …
disease (CHD), with most cases occurring in patients with congenital cardiac shunts. In …
Survival in pulmonary hypertension in Spain: insights from the Spanish registry
P Escribano-Subias, I Blanco… - European …, 2012 - Eur Respiratory Soc
A pulmonary hypertension (PH) registry (Spanish Registry of Pulmonary Arterial
Hypertension) was undertaken to analyse prevalence, incidence and survival of pulmonary …
Hypertension) was undertaken to analyse prevalence, incidence and survival of pulmonary …
Evaluation of macitentan in patients with Eisenmenger syndrome: results from the randomized, controlled MAESTRO study
MA Gatzoulis, M Landzberg, M Beghetti, RM Berger… - Circulation, 2019 - Am Heart Assoc
Background: Eisenmenger syndrome describes congenital heart disease-associated severe
pulmonary hypertension accompanied by right-to-left shunting. The multicenter, double …
pulmonary hypertension accompanied by right-to-left shunting. The multicenter, double …
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension
Rationale: Pulmonary arterial hypertension (PAH) is a medically incurable disease resulting
in death from right ventricular (RV) failure. Both pulmonary vascular and RV remodeling are …
in death from right ventricular (RV) failure. Both pulmonary vascular and RV remodeling are …
Iron deficiency is associated with adverse outcome in Eisenmenger patients
A Van De Bruaene, M Delcroix, A Pasquet… - European heart …, 2011 - academic.oup.com
Aims Iron deficiency is common in patients with Eisenmenger syndrome (ES). This study
aimed at evaluating (i) whether iron deficiency is related with adverse outcome,(ii) the …
aimed at evaluating (i) whether iron deficiency is related with adverse outcome,(ii) the …
Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions
MA Gatzoulis, M Beghetti, MJ Landzberg… - International journal of …, 2014 - Elsevier
Congenital heart disease (CHD), the most common inborn defect, affects approximately 1%
of all newborns worldwide. Advances in its diagnosis and treatment have led to a dramatic …
of all newborns worldwide. Advances in its diagnosis and treatment have led to a dramatic …
Pulmonary hypertension in adults with congenital heart disease: real-world data from the international COMPERA-CHD registry
H Kaemmerer, M Gorenflo, D Huscher… - Journal of clinical …, 2020 - mdpi.com
Introduction: Pulmonary hypertension (PH) is a common complication in patients with
congenital heart disease (CHD), aggravating the natural, post-operative, or post …
congenital heart disease (CHD), aggravating the natural, post-operative, or post …
[HTML][HTML] Prevalence and profile of congenital heart disease and pulmonary hypertension in Down syndrome in a pediatric cardiology service
FA Mourato, LRR Villachan, SS Mattos - Revista Paulista de Pediatria, 2014 - SciELO Brasil
OBJECTIVE: To determine the frequence and profile of congenital heart defects in Down
syndrome patients referred to a pediatric cardiologic center, considering the age of referral …
syndrome patients referred to a pediatric cardiologic center, considering the age of referral …
Clinical characteristics of pulmonary arterial hypertension associated with D own syndrome
T Saji - Pediatrics International, 2014 - Wiley Online Library
The genetic abnormalities associated with D own syndrome (DS) are still being identified.
Few studies have examined the roles of CRELD1 and GATA4 in cardiac abnormalities or …
Few studies have examined the roles of CRELD1 and GATA4 in cardiac abnormalities or …